Skip to content

The development of gait and balance assistive exoskeletal robot and the effects in patients with stroke

The development of gait and balance assistive exoskeletal robot and the effects in patients with stroke - The effects of gait and balance assistive exoskeletal robot in patients with stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022683
Enrollment
25
Registered
2016-06-09
Start date
2016-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic stroke

Interventions

Robot-assisted balance control and stepping in standing position

Sponsors

Keio University School of Medicine
Lead Sponsor
1.Advanced Telecommunications Research Institute International 2.Keio University School of Science and Technology 3.Tokyo Institute of Technology
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy subjects: 1.No medical history of motor musculoskeletal illness of lower extremity and neurological disorder 2.Agreement to participate in the research Patients: 1.Hemiparetic stroke patients with motor disability of lower extremity 2.At least 6 months after the stroke 3.No medical history of fracture and injury by fall within 3 months 4.Able to understand and consent the objective and method of the study 5.Able to keep standing position safely with or without assistance 6.Agreement to participate in the research

Exclusion criteria

Exclusion criteria: Healthy subjects and patients: 1.Serious cardiac disease: unstable angina, myocardial infarction shortly after symptom onset, decompensated congestive heart failure, acute cor pulmonale, uncontrolled arrhythmia, serious aortic stenosis, active myocarditis, endocarditis, etc. 2.Uncontrolled hypertension 3.Acute systemic disease or fever 4.Complication of recent pulmonary embolism, acute cor pulmonale or serious pulmonary hypertension 5.Complication of serious liver or renal dysfunction 6.Complication of serious orthopedic disease which bars exercise capability 7.Complication of serious cognitive dysfunction or psychiatric disorder 8.Other metabolic abnormality (acute thyroiditis, etc.) 9.Serious contractures of leg joints 10.Implanted electronic pacing or defibrillation devices. 11.Surgical history of shunting or clipping 12.Medical history of epilepsy

Design outcomes

Primary

MeasureTime frame
Motion analysis (joint angle, joint torque, and posturography) before, during, immediately after the intervention

Secondary

MeasureTime frame
Surface electromyography before, during, immediately after the intervention Gait analysis, electroencephalogram, and electrophysiological assessment (motor-evoked potential, intracortical inhibition/ facilitation, spinal reciprocal inhibition) before and immediately after the intervention

Countries

Japan

Contacts

Public ContactKatsuhiro Mizuno

Keio University School of Medicine Department of Rehabilitation Medicine

mizuno.katsuhiro@gmail.com03-5363-3833

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026